Publication | Closed Access
Tanshinone <scp>IIA</scp> improves contextual fear‐ and anxiety‐like behaviors in mice via the <scp>CREB</scp>/<scp>BDNF</scp>/<scp>TrkB</scp> signaling pathway
24
Citations
39
References
2022
Year
Ptsd Model MicePtsd Mouse ModelSynaptic SignalingSocial SciencesStressNeurochemistryCell SignalingPsychoneuroimmunologyMolecular NeuroscienceMolecular PhysiologyPsychiatryBehavioral NeuroscienceAnxiety‐like BehaviorsBehavioural PharmacologyBehavioral PharmacologyStress HormoneNeuropharmacologyNeuroprotectionContextual Fear‐PharmacologySynaptic PlasticitySignal TransductionNeuropeptide ReceptorNeuroscienceBiological PsychiatryMedicinePtsd TreatmentPost-traumatic Stress Disorder
Posttraumatic stress disorder (PTSD) is one of the most common psychiatric diseases, which is characterized by the typical symptoms such as re-experience, avoidance, and hyperarousal. However, there are few drugs for PTSD treatment. In this study, conditioned fear and single-prolonged stress were employed to establish PTSD mouse model, and we investigated the effects of Tanshinone IIA (TanIIA), a natural product isolated from traditional Chinese herbal Salvia miltiorrhiza, as well as the underlying mechanisms in mice. The results showed that the double stress exposure induced obvious PTSD-like symptoms, and TanIIA administration significantly decreased freezing time in contextual fear test and relieved anxiety-like behavior in open field and elevated plus maze tests. Moreover, TanIIA increased the spine density and upregulated synaptic plasticity-related proteins as well as activated CREB/BDNF/TrkB signaling pathway in the hippocampus. Blockage of CREB remarkably abolished the effects of TanIIA in PTSD model mice and reversed the upregulations of p-CREB, BDNF, TrkB, and synaptic plasticity-related protein induced by TanIIA. The molecular docking simulation indicated that TanIIA could interact with the CREB-binding protein. These findings indicate that TanIIA ameliorates PTSD-like behaviors in mice by activating the CREB/BDNF/TrkB pathway, which provides a basis for PTSD treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1